This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Preterm Birth, Bronchopulmonary Dysplasia or Chronic Lung Disease of Prematurity
and you are
under 7
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The goal of IMPROV is to identify molecular mechanisms that contribute to lung injury and long-term breathing problems in preterm infants by investigating two interrelated biochemical pathways: the urea cycle-nitric oxide pathway and the glutathione pathway. The investigators hypothesize that prematurity-related limitations in the function of these important biochemical pathways contribute to respiratory disease risk over the first year of life.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01460576. The sponsor of the trial is Vanderbilt University Medical Center and it is looking for 253 volunteers for the current phase.
Official trial title:
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt: The Prematurity and Respiratory Outcomes Program (PROP)